Holen Sie sich die Stockscreener-App
9.66
2.72%
-0.27
Handel nachbörslich:
9.85
0.19
+1.97%
Oric Pharmaceuticals Inc Aktie (ORIC) Neueste Nachrichten
Oric Pharmaceuticals' (ORIC) Buy Rating Reiterated at Guggenheim - MarketBeat
Oric Pharmaceuticals (NASDAQ:ORIC) Posts Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
A Quick Look at Today's Ratings for Oric Pharmaceuticals(ORIC.US), With a Forecast Between $12 to $23 - 富途牛牛
How to forecast ORIC Pharmaceuticals Inc. trends using time series2025 Trade Ideas & AI Powered Market Entry Strategies - Newser
Market reaction to ORIC Pharmaceuticals Inc.’s recent newsPortfolio Gains Report & Community Driven Trade Alerts - Newser
Signal strength of ORIC Pharmaceuticals Inc. stock in tech scannersQuarterly Profit Review & Stock Portfolio Risk Control - Newser
Oric Pharmaceuticals Faces Potential Setbacks Amid Competitors’ Clinical Trials - TipRanks
Jefferies Reiterates Buy Rating on Oric Pharmaceuticals with $23 Price Target. - AInvest
Guggenheim Reaffirms Buy Rating for ORIC Pharmaceuticals with $18 Target Price. - AInvest
Contineum Therapeutics shares fall 1.04% intraday after ORIC Pharmaceuticals reports positive clinical data and financing activity. - AInvest
Moving Average Trends for ORIC Pharmaceuticals Inc. Stock: What They IndicateWeekly Risk Report & Free Risk Controlled Daily Trade Plans - Newser
Guggenheim Reiterates Buy Rating for ORIC Pharmaceuticals | ORIC Stock News - GuruFocus
Guggenheim Keeps Buy Rating, Raises PT for ORIC Pharmaceuticals to $18. - AInvest
ORIC Pharmaceuticals stock price target raised to $23 by Jefferies - Investing.com Canada
Oric Pharmaceuticals Focuses on Lead Clinical Programs - MSN
How to manage a losing position in ORIC Pharmaceuticals Inc.2025 Pullback Review & Short-Term Trading Opportunity Alerts - Newser
ORIC Pharmaceuticals Inc. stock momentum explainedEarnings Miss & High Return Trade Opportunity Guides - Newser
Oppenheimer Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
Will ORIC Pharmaceuticals Inc. see short term momentum2025 Top Gainers & Fast Gain Stock Tips - Newser
Can volume confirm reversal in ORIC Pharmaceuticals Inc.Portfolio Return Summary & Precise Buy Zone Tips - Newser
Using flow based indicators on ORIC Pharmaceuticals Inc.Real-Time Investment Signal Forecast with AI - Newser
Using economic indicators to assess ORIC Pharmaceuticals Inc. potentialStrategy Playbook for Risk Controlled Trades - Newser
ORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Updates - GlobeNewswire
ORIC Pharmaceuticals Trims Costs To Back Key Drug Trials - Finimize
Vivo Capital LLC Buys 802,632 Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat
Oric Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
ORIC Pharmaceuticals reports Q2 net loss of $36.4 mln - MarketScreener
What makes ORIC Pharmaceuticals Inc. stock price move sharplySummary of Trade Cycles in 5-Year Range - Newser
Will a bounce in ORIC Pharmaceuticals Inc. offer an exitAI Trend Detection for Entry Timing - Newser
What data driven models say about ORIC Pharmaceuticals Inc.’s futureROI Prediction from Long-Term Holding Plans - Newser
What Fibonacci levels say about ORIC Pharmaceuticals Inc. reboundPrice Forecast Based on AI Analysis - Newser
ORIC Pharmaceuticals Inc.’s volatility index tracking explainedFree Breakout Confirmation With Entry Tracker - Newser
Volume spikes in ORIC Pharmaceuticals Inc. stock – what they meanAI Enhanced Strategy for Portfolio Growth - Newser
ORIC Pharmaceuticals Inc. Attempts Reversal From Key SupportDaily Stock Market Swing Alerts Highlight Key Movers - beatles.ru
Will ORIC Pharmaceuticals Inc. continue its uptrendReal-Time Entry Forecast with Accuracy Metrics - Newser
Is ORIC Pharmaceuticals Inc. a candidate for recovery playMonthly Long-Term Market Recap and Summary - Newser
Key resistance and support levels for ORIC Pharmaceuticals Inc.Bull Market Summary and Recovery Outlook - Newser
Is ORIC Pharmaceuticals Inc. a Top Dividend Stock to Watch in 2025In-Depth Stock Trading Volume Analysis - Newser
Using data filters to optimize entry into ORIC Pharmaceuticals Inc.Stock Market Watch with Smart Filters - Newser
Oric Pharmaceuticals (ORIC) to Release Quarterly Earnings on Monday - MarketBeat
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):